Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Palantirs Q3 earnings and guidance are the dominant focus, with traders debating whether results can clear a high bar as AI stocks face a broader repricing. Bulls expect continued growth and an outlook increase, while bears argue that even a beat may not support the valuation without stronger guidance.

Broadcom is caught in a semiconductor selloff as traders question whether massive hyperscaler AI spending can generate adequate returns, raising concerns about capex cuts and the companys reliance on a small group of large customers. Some see the decline as indiscriminate sector selling despite continued AI investment and Broadcoms role as a chip supplier, while others worry that financing arrangements and customer concentration add risk.

Cash Cat is drawing attention after a sharp, volatile rally on the Robinhood network, with traders pointing to exchange listingsincluding Upbitas a catalyst and watching for further momentum. Bullish holders frame dips as accumulation and speculate about a short squeeze, while skeptics call the moves pump-and-dump behavior and warn that gains have repeatedly faded.

Salesforce is caught in the broader debate over whether AI agents will weaken seat-based SaaS software or deepen reliance on established enterprise platforms. Traders connect pressure on CRM to sector-wide software weakness, including spillover from ServiceNow, while others see the pullback as an opportunity and argue Salesforces entrenched workflows can adapt to AI.

Oracles sharp selloff and failure to hold a rally after its Investor Day update are fueling debate over its debt-funded AI data-center expansion, heavy capital spending, and whether its large backlog will convert into cash flow. Bulls point to managements cash-flow and spending plans as evidence of a path forward, while bears remain concerned about financing risk and AI demand, with weakness in other major tech stocks adding pressure.

Liquidias settlement with United Therapeutics resolved the companies pending lawsuits and keeps YUTREPIA on the market for PAH, while giving up the PH-ILD indication. Traders are reacting to the reduced risk of a broader sales interruption with optimism about a rebound and potential short covering, while others focus on the lost market opportunity and substantial settlement payments as risks to future growth and cash.

A SemiVision observers claim that POET optical hardware appeared in Foxconns photonics ecosystem at Hon Hai Tech Day is fueling speculation that the FIT relationship is progressing and could lead to orders. Traders see it as technical validation, but others stress that a demo does not confirm commercial shipments or purchase orders and are looking to upcoming results for evidence of execution.

Binances reported major security breach is weighing on crypto sentiment, with traders debating whether renewed withdrawal and trust concerns could extend selling across ETH and the broader market. Some see the selloff as a buying opportunity and distinguish an exchange breach from a failure of Ethereum itself, while others warn of further downside.

QQQ is drawing attention after a sharp Nasdaq selloff, with traders pointing to Big Tech earnings and concerns that heavy AI spending may not translate into near-term revenue and cash flow; elevated oil prices and uncertainty around Iran add to the risk-off discussion. Traders are split between expecting further downside and betting on an oversold rebound amid hopes for diplomatic progress and a busy midterm and earnings calendar.

IBB is drawing attention as traders discuss a biotech-sector rebound and the ETF holding near highs, with some attributing the strength to rotation from technology and semiconductors. Views are broadly constructive but selective: large-cap biotech is seen as steadier while smaller biotech names remain more volatile, amid a busy stretch of pharma earnings and clinical catalysts.